Dr. Leon Albert Bynoe, MD

Dr. Bynoe practices at Coral Springs Primary Care in Coral Springs, Florida.

Dr. Bynoe's NPI, 1023005212, was assigned on October 3, 2005. Dr. Bynoe graduated from The Johns Hopkins University School of Medicine in 1991. Dr. Bynoe holds Florida license ME 78447.

Dr. Bynoe's primary practice is Coral Springs Primary Care, at 1881 N University Dr Ste 100, Coral Springs, FL 33071. The practice phone is (954) 516-0070.

Dr. Bynoe's primary practice is Coral Springs Primary Care in Coral Springs, Florida. Dmand AI also links Dr. Bynoe to 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bynoe practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Bynoe's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Bynoe is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Bynoe's licenses on file in 2 states: Florida and Maryland.

Dmand AI lists age-related macular degeneration, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion, surgical retina and vitreous procedures and vitreous eye degeneration among the conditions Dr. Bynoe treats.

CMS data shows 1,142 Medicare services from Dr. Bynoe across 8 procedure codes in 2024, for 84 Medicare patients. Medicare paid $203,279 for them. Every service was in an office.

CMS counts 84 Medicare patients who saw Dr. Bynoe in 2024. The largest group is 75 to 84, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bynoe's median patient age at 72, with 54% women.

In 2024, Dr. Bynoe wrote 179 Medicare Part D claims for 46 patients. 27% of them were for generic drugs. CMS names the drug for 149 of them, across 5 drugs with 11 or more claims each, at $182,656 in total drug cost. In 2023, CMS named 135 claims across 4 drugs.

Dr. Bynoe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Bynoe in 2023. The most frequent topics are Light, Macular Degeneration and Protoporphyrins. Dr. Bynoe has published most often in Invest Ophthalmol Vis Sci. Dr. Bynoe's most frequent co-authors are Thomas A. Albini, MD, Joseph T. Nezgoda, MD and Philip J. Rosenfeld, MD.

CMS Open Payments shows 22 general payments to Dr. Bynoe from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $459.

Dmand AI lists 1 award for Dr. Bynoe, most recently CMS Stage 1 2012 in 2012.

Dr. Bynoe graduated from The Johns Hopkins University School of Medicine in 1991. Dr. Bynoe is a member of AAO.

Dr. Bynoe is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.